Anji Pharma and Population Health Partners Enter into Strategic Collaboration
19 Oct 2022 //
BUSINESSWIRE
Anji Pharma Provides Update on ANJ900 Pivotal Program
02 Jun 2022 //
BUSINESSWIRE
Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat
18 May 2022 //
BUSINESSWIRE
Eli Lilly-backed IpiNovyx Bio snags $10M for 2023 clinical entry
05 Oct 2021 //
FIERCEBIOTECH
Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset
29 Sep 2021 //
FIERCEBIOTECH